Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-23 8:20 pm Sale | 2024-12-23 | 13D | RAPT Therapeutics, Inc. RAPT | The Column Group II, LP | 200,449 4.900% | -352,731 (-63.76%) | Filing History |
| 2024-12-23 4:42 pm Purchase | 2024-12-23 | 13G | RAPT Therapeutics, Inc. RAPT | Deep Track Capital, LP | 1,764,500 9.870% | 1,764,500 (New Position) | Filing History |
| 2024-11-14 1:22 pm Sale | 2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | T. Rowe Price Associates, Inc. | 21,972 0.500% | -404,722 (-94.85%) | Filing History |
| 2024-11-14 09:39 am Sale | 2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | Deep Track Capital, LP | 0 0.000% | -224,246 (Position Closed) | Filing History |
| 2024-11-12 4:59 pm Unchanged | 2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | The Vanguard Group | 394,501 9.040% | 0 (Unchanged) | Filing History |
| 2024-11-12 10:34 am Purchase | 2024-11-08 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 654,440 14.999% | 174,017 (+36.22%) | Filing History |
| 2024-11-04 1:30 pm Purchase | 2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | The Vanguard Group | 394,501 9.040% | 137,473 (+53.49%) | Filing History |
| 2024-02-14 4:41 pm Purchase | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Perceptive Advisors LLC | 267,494 6.200% | 42,624 (+18.96%) | Filing History |
| 2024-02-14 4:26 pm Purchase | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Redmile Group, LLC | 472,106 9.900% | 12,126 (+2.64%) | Filing History |
| 2024-02-14 10:03 am Sale | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | T. Rowe Price Associates, Inc. | 426,694 9.900% | -17,864 (-4.02%) | Filing History |
| 2024-02-14 08:52 am Sale | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Deep Track Capital, LP | 224,246 5.220% | -24,680 (-9.91%) | Filing History |
| 2024-02-13 5:12 pm Purchase | 2023-12-29 | 13G | RAPT Therapeutics, Inc. RAPT | The Vanguard Group | 257,028 5.980% | 257,028 (New Position) | Filing History |
| 2024-02-09 09:49 am Sale | 2024-02-08 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 480,423 11.173% | -10,502 (-2.14%) | Filing History |
| 2024-01-26 4:23 pm Purchase | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | BlackRock Inc. BLK | 306,631 7.100% | 68,691 (+28.87%) | Filing History |
| 2024-01-23 10:19 am Sale | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | STATE STREET CORP STT | 181,820 4.230% | -60,771 (-25.05%) | Filing History |
| 2023-10-23 4:40 pm Purchase | 2023-10-13 | 13G | RAPT Therapeutics, Inc. RAPT | Deep Track Capital, LP | 248,925 5.800% | 248,925 (New Position) | Filing History |
| 2023-06-12 2:10 pm Purchase | 2023-05-31 | 13G | RAPT Therapeutics, Inc. RAPT | T. Rowe Price Associates, Inc. | 444,558 10.400% | 23,947 (+5.69%) | Filing History |
| 2023-02-14 4:21 pm Purchase | 2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Redmile Group, LLC | 459,980 9.900% | 60,059 (+15.02%) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Perceptive Advisors LLC | 224,869 5.300% | -141,076 (-38.55%) | Filing History |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | T. Rowe Price Associates, Inc. | 420,611 9.900% | -72,850 (-14.76%) | Filing History |